Fall Unified Agenda: A look at FDA’s planned rulemaking
Regulatory NewsMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyMedical DevicesNorth AmericaOTCPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMichael MezherBiologics/ biosimilars/ vaccinesBiotechnologyMedical DevicesNorth AmericaOTCPharmaceuticalsRegulatory Intelligence/Policy